These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11872630)

  • 1. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
    Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
    Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
    Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
    Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
    Ito M; Habuchi T; Watanabe J; Higashi S; Nishiyama H; Wang L; Tsuchiya N; Kamoto T; Ogawa O
    Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.
    Cortessis VK; Siegmund K; Xue S; Ross RK; Yu MC
    Carcinogenesis; 2003 Oct; 24(10):1645-50. PubMed ID: 12896908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
    Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
    Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
    Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 polymorphism and the risk of endometrial cancer.
    Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
    Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
    Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Djukic T; Simic T; Radic T; Matic M; Pljesa-Ercegovac M; Suvakov S; Coric V; Pekmezovic T; Novakovic I; Dragicevic D; Savic-Radojevic A
    Int Urol Nephrol; 2015 Apr; 47(4):625-30. PubMed ID: 25716313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
    Weng WC; Huang YH; Yang SF; Wang SS; Kuo WH; Hsueh CW; Huang CH; Chou YE
    Tumour Biol; 2016 May; 37(5):6971-7. PubMed ID: 26662954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
    Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
    DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
    Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
    Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
    Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
    Forones NM; de Lima JM; de Souza LG; da Silva ID
    J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma.
    Yu J; Habuchi T; Tsuchiya N; Nakamura E; Kakinuma H; Horikawa Y; Inoue T; Ogawa O; Kato T
    J Urol; 2004 Dec; 172(6 Pt 1):2410-3. PubMed ID: 15538282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.